United Therapeutics
UTHR
#960
Rank
ยฃ18.90 B
Marketcap
ยฃ443.96
Share price
-0.40%
Change (1 day)
23.80%
Change (1 year)

EPS for United Therapeutics (UTHR)

EPS in 2026 (TTM): ยฃ21.49

According to United Therapeutics's latest financial reports the company's current EPS (TTM) is ยฃ21.69. In 2025 the company made an earnings per share (EPS) of ยฃ22.88 an increase over its 2024 EPS that were of ยฃ20.05.

EPS history for United Therapeutics from 2013 to 2026

Annual EPS

Year EPS Change
2026 (TTM)ยฃ21.49-6.1%
2025ยฃ22.8814.1%
2024ยฃ20.0525.59%
2023ยฃ15.9731.54%
2022ยฃ12.1451.18%
2021ยฃ8.03-9.1%
2020ยฃ8.83-581.4%
2019-ยฃ1.83-117.79%
2018ยฃ10.3142.11%
2017ยฃ7.26-40.93%
2016ยฃ12.2813.45%
2015ยฃ10.83104.29%
2014ยฃ5.30100.29%
2013ยฃ2.65

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Pfizer
PFE
ยฃ0.54-97.52%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
ยฃ23.42 7.97%๐Ÿ‡บ๐Ÿ‡ธ USA
Baxter
BAX
-ยฃ1.07-104.93%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
-ยฃ2.35-110.84%๐Ÿ‡บ๐Ÿ‡ธ USA
Cardinal Health
CAH
ยฃ5.88-72.88%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
ยฃ2.18-89.94%๐Ÿ‡ฌ๐Ÿ‡ง UK
Cytokinetics
CYTK
-ยฃ4.58-121.11%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
ยฃ0.34-98.43%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel